Efficacy of intra-arterial fibrinolysis for acute ischemic stroke: Meta-analysis of randomized controlled trials

Stroke

Volumn 41, Issue 5, 2010, Pages 932-937

  Lee, Meng ^a,b   Hong, Keun Sik ^a,c   Saver, Jeffrey L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c Inje University College of Medicine   (South Korea)

Author keywords

Acute ischemic stroke; Fibrinolysis; Intra arterial; Meta analysis; Outcomes

Indexed keywords

FIBRINOLYTIC AGENT; HEPARIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ARTICLE; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; CLINICAL TRIAL; DAILY LIFE ACTIVITY; DRUG EFFICACY; DRUG SAFETY; FIBRINOLYSIS; HUMAN; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECANALIZATION; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW;

AGED; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE;

EID: 77951768941     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.574335     Document Type: Article

References (31)

1. Johnston SC, Mendis S, Mathers CD. Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. Lancet Neurol. 2009;8:345-354.
2. Lee KY, Han SW, Kim SH, Nam HS, Ahn SW, Kim DJ, Seo SH, Kim DI, Heo JH. Early recanalization after intravenous administration of recombinant tissue plasminogen activator as assessed by pre-and post-thrombolytic angiography in acute ischemic stroke patients. Stroke. 2007;38:192-193.
3. Zeumer H, Hacke W, Ringelstein EB. Local intra-arterial thrombolysis in vertebrobasilar thromboembolic disease. AJNR Am J Neuroradiol. 1983; 4:401-404.
4. Peto R. Why do we need systematic overviews of randomized trials? Stat Med. 1987;6:233-244. (Pubitemid 17107616)
5. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement: Quality of Reporting of Metaanalyses. Lancet. 1999;354:1896-1900.
6. Liebeskind DS, Kidwell CS, Sayre JW, Saver JL. Evidence of publication bias in reporting acute stroke clinical trials. Neurology. 2006;67:973-979. (Pubitemid 44454587)
7. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560.
8. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539-1558.
9. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. West Sussex: Cochrane Collaboration and John Wiley & Sons Ltd; 2008.
10. Yusuf S, Peto R, Lewis J, Collins R, Sleight P./3-Blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985;27:335-371. (Pubitemid 15107153)
11. Ducrocq X, Bracard S, Taillandier L, Anxionnat R, Lacour JC, Guillemin F, Debouverie M, Bollaert PE. Comparison of intravenous and intra-ar-terial urokinase thrombolysis for acute ischaemic stroke. J Neuroradiol. 2005;32:26-32.
12. Sen S, Huang DY, Akhavan O, Wilson S, Verro P, Solander S. IV vs. IA TPA in acute ischemic stroke with CT angiographic evidence of major vessel occlusion: a feasibility study. Neurocrit Care. 2009;11:76-81.
13. Lewandowski CA, Frankel M, Tomsick TA, Broderick J, Frey J, Clark W, Starkman S, Grotta J, Spilker J, Khoury J, Brott T. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke. 1999;30:2598-2605.
14. Wang F, Yang H, Chu L-Z, Hu Y-C, Sui J-M, Liu J. Combined intravenous and intra-arterial infusion of recombinant tissue plasminogen activator for treatment of acute ischemic stroke. Chin J Cerebrovasc Dis. 2007;4:160-163. (Pubitemid 46730433)
15. Kandil MR. Intra-arterial urokinase in acute stroke. XVII World Congress of Neurology. London, UK. June 17-22, 2001;187:S256. Abstract.
16. Wardlaw JM, Lindley RI, Warlow CP, Sandercock PAG. A pilot study of intra-arterial thrombolysis for acute ischaemic stroke. J Neurol Nuerosurg Psychiatry. 1994;57:251. Abstract.
17. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke. 1998;29:4-11.
18. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. J Am Med Assoc. 1999;282:2003-2011.
19. Keris V, Rudnicka S, Vorona V, Enina G, Tilgale B, Fricbergs J. Combined intra-arterial/intravenous thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol. 2001;22:352-358. (Pubitemid 32163468)
20. Macleod MR, Davis SM, Mitchell PJ, Gerraty RP, Fitt G, Hankey GJ, Stewart-Wynne EG, Rosen D, McNeil JJ, Bladin CF, Chambers BR, Herkes GK, Young D, Donnan GA. Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovasc Dis. 2005;20:12-17. (Pubitemid 41003629)
21. Ogawa A, Mori E, Minematsu K, Taki W, Takahashi A, Nemoto S, Miyamoto S, Sasaki M, Inoue T. Randomized trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke. 2007;38:2633-2639. (Pubitemid 47493996)
22. Wardlaw JM, Murray V, Berge E, Del Zoppo GJ. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev. 2009:CD000213.
23. Molina CA, Alvarez-Sabin J, Montaner J, Abilleira S, Arenillas JF, Coscojuela P, Romero F, Codina A. Thrombolysis-related hemorrhagic infarction: a marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion. Stroke. 2002;33:1551-1556. (Pubitemid 34619956)
24. Berger C, Fiorelli M, Steiner T, Schabitz WR, Bozzao L, Bluhmki E, Hacke W, von Kummer R. Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke. 2001;32:1330-1335. (Pubitemid 32530418)
25. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke. 2007;38:967-973. (Pubitemid 46568460)
26. Saver JL. Number needed to treat estimates incorporating effects over the entire range of clinical outcomes: novel derivation method and application to thrombolytic therapy for acute stroke. Arch Neurol. 2004;61: 1066-1070. (Pubitemid 38915948)
27. Kidwell CS, Alger JR, Saver JL. Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke. 2003;34:2729-2735.
28. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333:1581-1587.
29. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317-1329.
30. Mattle HP, Arnold M, Georgiadis D, Baumann C, Nedeltchev K, Ben-ninger D, Remonda L, von Budingen C, Diana A, Pangalu A, Schroth G, Baumgartner RW. Comparison of intra-arterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign. Stroke. 2008;39:379-383. (Pubitemid 351619459)
31. Schonewille WJ, Wijman CA, Michel P, Rueckert CM, Weimar C, Mattle HP, Engelter ST, Tanne D, Muir KW, Molina CA, Thijs V, Audebert H, Pfefferkorn T, Szabo K, Lindsberg PJ, de Freitas G, Kappelle LJ, Algra A. Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study. Lancet Neurol. 2009;8:724-730.